Product

SCB-2020S

1 clinical trial

1 indication

Indication

Clinical trial

A Phase 1, Observer-blind, Randomized, Controlled, Dose-finding Study to Evaluate the Safety and Immunogenicity of Clover Adjuvanted Recombinant SARS-CoV-2 Trimeric S-protein Subunit Vaccine (SCB-2020S) in Adults 18 to 75 Years of Age

Status: Completed, Estimated PCD: 2022-09-23